cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Maxcyte Inc
12 own
17 watching
Current Price
$3.03
$-0.09
(-2.88%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
311.25M
52-Week High
52-Week High
7.50000
52-Week Low
52-Week Low
2.99500
Average Volume
Average Volume
0.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization311.25M
icon52-Week High7.50000
icon52-Week Low2.99500
iconAverage Volume0.32M
iconDividend Yield--
iconP/E Ratio--
What does the Maxcyte Inc do?
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Maxcyte Inc make?
News & Events about Maxcyte Inc.
Globe Newswire
6 months ago
MaxCytes Scientific Advisory Board will provide guidance to shape the technical direction of the companys innovation initiatives focused on the discovery, development and manufacturing of next-generation, cell-based medicinesROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: ...
Globe Newswire
10 months ago
Curamys to use MaxCytes Flow Electroporation technology and ExPERT platform to help advance its cell fusion technology.ROCKVILLE, Md. and SEOUL, South Korea, Dec. 04, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling ...
Ticker Report
11 months ago
MaxCyte, Inc. (NASDAQ:MXCT Get Rating) EVP Thomas M. Ross sold 4,282 shares of the businesss stock in a transaction that occurred on Tuesday, October 11th. The stock was sold at an average price of $6.51, for a total transaction of $27,875.82. The transaction was disclosed in a filing...
Ticker Report
1 year ago
MaxCyte (NASDAQ:MXCT Get Rating) had its target price raised by BTIG Research from $10.00 to $11.00 in a report issued on Sunday, The Fly reports. MaxCyte Price Performance Shares of MXCT opened at $5.87 on Friday. The stock has a market capitalization of $596.55 million and a P/E ratio of -...
Globe Newswire
1 year ago
GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, ...
Frequently Asked Questions
Frequently Asked Questions
What is Maxcyte Inc share price today?
plus_minus_icon
Can Indians buy Maxcyte Inc shares?
plus_minus_icon
How can I buy Maxcyte Inc shares from India?
plus_minus_icon
Can Fractional shares of Maxcyte Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Maxcyte Inc stocks?
plus_minus_icon
What is today’s traded volume of Maxcyte Inc?
plus_minus_icon
What is today’s market capitalisation of Maxcyte Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Maxcyte Inc?
plus_minus_icon
What percentage is Maxcyte Inc down from its 52-Week High?
plus_minus_icon
What percentage is Maxcyte Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.03
$-0.09
(-2.88%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00